DIM
REPL icon

DC Investments Management’s Replimune Group REPL Stock Holding History

DC Investments Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-39,578
Closed -$637K – 298
2018
Q3 		$637K Buy
+39,578
New +$694K 0.43% 43

Other funds holding REPL

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DC Investments Management's REPL Position: Q4 2018 in Review

DC Investments Management sold out of Replimune Group (REPL) in Q4 2018, closing a stake of 39,578 shares — an estimated $637K sold.

DC Investments Management first reported a position in REPL in Q3 2018 and held it in 1 quarter. The position peaked at $637K in Q3 2018. 51 funds tracked by Wall St. Rank hold REPL as of Q4 2018.

  • DC Investments Management reported no remaining Replimune Group position as of Q4 2018 after selling out during the quarter.
  • DC Investments Management sold 39,578 Replimune Group shares in Q4 2018, an estimated $637K.
  • DC Investments Management first reported a position in Replimune Group in Q3 2018 and held it in 1 quarter.
  • DC Investments Management's Replimune Group position peaked at $637K in Q3 2018.
  • 51 funds tracked by Wall St. Rank held Replimune Group as of Q4 2018.

Based on DC Investments Management's 13F filing for Q4 2018, filed 8 Feb 2019.